A recent review demonstrated that three frequently studied polymorphisms in ABCB1 (rs1045642, rs1128503, and rs2032582) cannot be considered reliable predictors of response to chemotherapy in breast cancer patients [38]. The gene discussed is ABCB1; the disease is breast cancer.